Unregulated use of <i>Artemisia</i> in cancer patients in Libya: an emerging ethical and public health concern
A concerning trend has recently emerged in Libya where cancer patients are seeking unproven herbal remedies derived from local Artemisia species driven by circulating claims on social media. These unregulated traditional medicines can interact with standard cancer treatments such as chemotherapy and radiation therapy. Scientific evidence suggests that <i>Artemisia</i> compounds can alter drug metabolism through enzymatic pathways (notably the CYP450 system), potentially neutralizing treatment efficacy or exacerbating systemic toxicity. This letter evaluates the toxicological profile of <i>Artemisia</i> and proposes an ethical framework for patient protection and public health intervention in Libya.
Authors
- Inas M. Alhudiri (ORCID: https://orcid.org/0000-0002-3371-0215)
- Fawzi Ebrahim
Institutions
- Biotechnology Research Center (IR)
- Cell and Tissue Systems (United States) (US)
Publication Details
- Journal
- Libyan Journal of Medicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1080/19932820.2025.2611580
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00